iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares REMUS REMUS PHARMACEUTICALS LIMITED INE0O5T01011 Board Meeting New 2025-11-10 Yes 2025-10-01 2025-11-12 Financial results Dividend Other business Unaudited Standalone And Consolidated Half Yearly September 2025 Interim The Company has fixed Friday, November 14, 2025 as the Record Date for reckoning the shareholders who shall be entitled to receive the interim dividend, if any, so declared in the Board Meeting scheduled to be held on November 10, 2025.